CooperVision introduced the Brilliant Futures Myopia Management Program to create a new standard of care for children with myopia, as the company prepares to launch its myopia control contact lens.
The MiSight 1-day lens, which was approved by the FDA for slowing progression of myopia in children between 8 and 12 years old, will be used in conjunction with the Brilliant Futures program to provide support for children and parents, according to a press release from the company.
“We believe success in addressing the rising severity and prevalence of myopia progression involves commitments from the parent, the child and the practitioner. This is why we are taking a new approach to partnering with eye care practitioners to help them achieve the best possible outcomes,” Michele Andrews, OD, CooperVision senior director of professional and academic affairs, North America, noted in the release.
Features of the program for patients include transparent protocol for care, free product shipping and an interactive app to keep patients engaged. Additionally, eye care providers who gain certification to implement this new program will receive extensive backing. This will include ongoing education, specialist support and a management toolbox of patient and parent educational tools, staff training tools, practice integration support and community engagement resources.
“I’m a firm believer that effective communication leads to better outcomes through increased compliance — especially when outlining a myopia diagnosis and treatment plan to my pediatric patients and their parents,” Roxanne Achong-Coan, OD, FAAO, FIAOMC, FSLS, said in the release. “CooperVision’s Brilliant Futures Myopia Management Program has several great education tools for me and my staff to use. It will be a great asset to my practice, and I am looking forward to offering this program to my patients.”